Delivery Order SPE2DB22D2007-SPE2DB24FJ2MH
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,147.76 firm fixed-price contract is for the delivery of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 16, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $1,058.88 for the procurement of FEXOFENADINE HCL 180 MG TABLET 500S. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,201,800 tablets of the prescription medication Fexofenadine HCL 180 mg, with a ceiling value of $2,698.70. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,206.90 firm fixed-price delivery order is for the supply of 4,564,852,598 units of Fexofenadine HCl 180 mg tablets. The contract has an ultimate completion date of June 11, 2024 and was awarded on June 10, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,337.28, is for the delivery of 4,567,094,436 units of the drug Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation or subcontractors....
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,533 units of Fexofenadine HCL 180 mg tablets. The $1,340.43 ceiling value contract has a completion date of September 21, 2022. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov) until June 2025, has an extensive history of providing pharmaceutical and medical products...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $1,640.52 firm fixed price contract is for the delivery of 4,558,478,347 units of Fexofenadine HCL 180 mg tablets. This order is made under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and will...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.19, is a delivery order for the supply of Fexofenadine HCL 180 mg tablets. It is a firm fixed-price contract with a completion date of February 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,430.38, is for the delivery of fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price type. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,390.41, is for the procurement of fexofenadine hydrochloride 180 mg tablets, a prescription medication. The contract has an ultimate completion date of July 11, 2024 and is a firm fixed-price delivery order. The award is not associated with a set-aside designation, indicating open competition....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ2MHDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,349.56, is for the supply of 4564589680 - FEXOFENADINE HCL 180 MG TABLET 100S. The order is placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed-price pricing type and a completion date of May 14, 2024. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/13/24 |